Dofequidar
Dofequidar (MS-209 free base) is an orally bioavailable quinoline-based compound that functions as a multidrug resistance (MDR) inhibitor by targeting efflux transporters such as ABCB1/P-gp and ABCC1/MRP1. It has been investigated in vitro and in vivo to sensitize cancer cells to chemotherapeutic agents and overcome treatment resistance.
Product Specifications
CAS Number
129716-58-1
Field of Research
Neuroscience, Pharmacology & Drug Discovery
Smiles
O=C (N1CCN (CC1) CC (O) COC2=CC=CC3=NC=CC=C32) C (C=4C=CC=CC4) C=5C=CC=CC5
Molecular Formula
C30H31N3O3
Molecular Weight
481.59
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
038375-ML550 100 µL
Metabotropic Glutamate Receptor 3, CT (GRM3, GPRC1C, MGLUR3, Metabotropic glutamate receptor 3) (MaxLight 550) discontinued
Sign In for Pricing
View Details 032396-ML650 100 µL
BAD, phosphorylated (S112) (Bad, Bbc6, Bcl2 antagonist of cell death, Bcl-2-binding component 6, Bcl-xL/Bcl-2-associated death promoter) (MaxLight 650) discontinued
Sign In for Pricing
View Details 